MIU-[N,N-BIS-(DIPYRROLYLPHOSPHINO)-N-METHYLAMINE]-TETRACARBONYL-MIU-[2-ETA:2-ETA-PHENYLACETYLENE]-DICOBALT
Compound with spectra: 1 NMR
![MIU-[N,N-BIS-(DIPYRROLYLPHOSPHINO)-N-METHYLAMINE]-TETRACARBONYL-MIU-[2-ETA:2-ETA-PHENYLACETYLENE]-DICOBALT](/api/compound/FcaT1F8E3w9.png?ph=true&h=300&w=458 "MIU-[N,N-BIS-(DIPYRROLYLPHOSPHINO)-N-METHYLAMINE]-TETRACARBONYL-MIU-[2-ETA:2-ETA-PHENYLACETYLENE]-DICOBALT")
| SpectraBase Compound ID | FcaT1F8E3w9 |
|---|---|
| InChI | InChI=1S/C17H19N5P2.C6H5.C2H4.4CO.2Co.H/c1-18(23(19-10-2-3-11-19)20-12-4-5-13-20)24(21-14-6-7-15-21)22-16-8-9-17-22;1-2-4-6-5-3-1;5*1-2;;;/h2-17H,1H3;1-5H;1-2H2;;;;;;;/q;;;;;;;2*-1;/p+2 |
| InChIKey | ZEYRGVKPHIGGQP-UHFFFAOYSA-P |
| Mol Weight | 693.41 g/mol |
| Molecular Formula | C29H31Co2N5O4P2 |
| Exact Mass | 693.051516 g/mol |
| Parent InChIKey | KOJSQQOFVTUYRL-UHFFFAOYSA-P |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1,1,2',2'-Tetraethyl-1',2',3',8',9',10',11',23',34',35',36',35'a-dodecahydro-14'-20'-38'-41'-tetramethylspiro[piperidine-4,17'-[4,6:13,16:18,21]trietheno[28,32:31,35]dimethano[17H][1,6,16,21]tetraoxacyclotriacontino[25,24-c]pyridinium]Dichloride
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
41,42,43,44,45,46,47,48-Octamethoxy-4,9,14,19,24,29,34,39-octamethylnonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
(4a.alpha.,4b.alpha.,4c.beta.,5.alpha.,8.alpha.,8a.beta.,8c.alpha.)-2,4b,5,8,8b,11-Hexamethyl-6,7-diphenyl-4,4b,5,8,8b,9-hexahydro-4c,8a-(methaniminomethano)-5,8-methano-1H-benzo[3',4']cyclobuta[1',2':3,4]cyclobuta[1,2-f]isoindole-1,3,10,12,13(2H)-pentone
2-(2'-acetoxymethyl-3'-(2",3",4"-tri(trimethylsiloxy).alpha.-L-rhamnosyloxy)-4'-(2"-phenyl-2"-trimethylsiloxyethylcarbonyloxy)-5'-(2"-methylpropylcarbonylamino)-1'-oxacycloheh-1'-yloxy)-4,4-di(trimethylsiloxycarbonyl)-8,13-ethano-15-hydroxy-16-methylene-perhydrophenanthrane
tetramethyl (2.alpha.,3.alpha.,6.beta.,8.beta.,10.beta.,12.beta.,15.alpha.,16.alpha.)-19-endo,23-endo,27-exo-9,21-dioxo-7,11,19,23,27,28-hexaoxaundecacyclo[15.7.2.1(2,16),1(4,14).0(1,17).0(3,15).0(5,13).0(6,8).0(10,12).0(18,20).0(22,24)]octacosa-5(13),25-diene-3,15,25,26-tetracarboxylate
2-Propenoic acid, 3-phenyl-, 1,1a,1b,1c,2a,3,3a,4,6a,6b,7,8-dodecahydro-3a,6b-dihydroxy-1,1,5,7-tetramethyl-4-oxo-2a-[[(1-oxo-3-phenyl-2-propenyl)oxy]methyl]-8aH-cyclopropa[5',6']benz[1',2':7,8]az uleno[5,6-b]oxirene-8,8a-diyl ester, [1aR-(1a.alpha.,1b.beta.,1c.beta.,2a.beta.,3a.beta.,6a.alpha.,6b.alpha.,7.alpha.,8.beta.,8a.alpha.)]-
Dispiro[piperidine-4,2'-[7,14,24,31]tetraoxapentacyclo[30.2.2.23,6.215,18.220,23]dotetraconta[3,5,15,17,20,22,32,34,35,37,39,41]dodecaen e-19',4''-piperidine], 1,1''-diacetyl-5',33'-dibromo-16',22',36',37',40',41'-hexamethyl-
N-[4-((2-chloro-4-sulfophenyl){3-methyl-4-[(3-sulfobenzyl)amino]phenyl}methylene)-2-methyl-2,5-cyclohexadien-1-ylidene](3-sulfophenyl)methanaminium trihydrogen [(trioxotungstato)(trioxomolybdato)phosphate]
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Characterization of New Binuclear Co(0) Complexes with Diphosphinoamine Ligands. A Potential Approach for Asymmetric Pauson−Khand Reactions | The Journal of Organic Chemistry | 1999 |